Cushman, William C <br/><br/>
Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Aug 2012 
 - 310-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/HYPERTENSIONAHA.111.188284  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Benzimidazoles--pharmacology<br/>Black People<br/>Blood Pressure--drug effects<br/>Chlorthalidone--pharmacology<br/>Diuretics--pharmacology<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hydrochlorothiazide--pharmacology<br/>Hypertension--classification<br/>Imidazoles--pharmacology<br/>Male<br/>Middle Aged<br/>Oxadiazoles--pharmacology<br/>Severity of Illness Index<br/>Tetrazoles--pharmacology<br/>Treatment Outcome<br/>White People